View in EDS PDF Full Text

Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer.

Saved in:
Bibliographic Details
Title: Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer.
Authors: Domingos-Pereira, Sonia1, Cesson, Valérie1, Chevalier, Mathieu F.1, Derré, Laurent1, Jichlinski, Patrice1, Nardelli-Haefliger, Denise1
Source: OncoImmunology. 2017, Vol. 6 Issue 1, p1-1. 1p.
Database: Academic Search Ultimate
Description
ISSN:21624011
DOI:10.1080/2162402X.2016.1265720